-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics Q1 EPS $(0.85) Beats $(1.29) Estimate

Benzinga·05/15/2026 22:58:51
Listen to the news
Silexion Therapeutics (NASDAQ:SLXN) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(1.29) by 34.11 percent. This is a 77.86 percent increase over losses of $(3.84) per share from the same period last year.